This study indicated that mangiferin, as an effective antifibrogenic agent, regulated the PTEN/PI3K/Akt pathway, thereby inhibiting the renal interstitial fibrosis in DN by reducing the TGF-β1-induced elevation of Col I, FN, and α-SMA. This evidence concerns the gene PTEN and liver dysplastic nodule.